[
  {
    "ts": null,
    "headline": "2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon",
    "summary": "For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.",
    "url": "https://finnhub.io/api/news?id=9a00803b782ec2458fe2324b383b14045226d2ea3477245095fc90dbaa9fcc89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763821200,
      "headline": "2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon",
      "id": 137578956,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.",
      "url": "https://finnhub.io/api/news?id=9a00803b782ec2458fe2324b383b14045226d2ea3477245095fc90dbaa9fcc89"
    }
  },
  {
    "ts": null,
    "headline": "Does Pfizer’s AI-Powered R&D Signal a New Opportunity for 2025?",
    "summary": "Wondering if Pfizer is a smart buy at today's price? You are not alone, especially as value-focused investors begin to focus on the stock. Pfizer's performance has been mixed lately. Shares dipped just 0.1% in the last week, inched up 1.3% over the past month, but are still down 5.9% year to date despite a 4.7% return over the last twelve months. Recent headlines about Pfizer have focused on its latest product developments and major moves in the pharmaceutical sector, generating speculation...",
    "url": "https://finnhub.io/api/news?id=b361c6487cac69be89572ac7548e40b0a3b1791448116f7834617ec6cc26961f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763792544,
      "headline": "Does Pfizer’s AI-Powered R&D Signal a New Opportunity for 2025?",
      "id": 137578957,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Wondering if Pfizer is a smart buy at today's price? You are not alone, especially as value-focused investors begin to focus on the stock. Pfizer's performance has been mixed lately. Shares dipped just 0.1% in the last week, inched up 1.3% over the past month, but are still down 5.9% year to date despite a 4.7% return over the last twelve months. Recent headlines about Pfizer have focused on its latest product developments and major moves in the pharmaceutical sector, generating speculation...",
      "url": "https://finnhub.io/api/news?id=b361c6487cac69be89572ac7548e40b0a3b1791448116f7834617ec6cc26961f"
    }
  }
]